OFFMANAGE
ActiveSummary
OFFMANAGE has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €47,687 and a net result of €22,476. Its solvency ranks better than 71% of 39,293 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 14-07-2022 Normal situation
- Activity
- Business and other management consultancy NACE 70200and 2 others
- Establishment unit
- 2.333.706.073 9000 Gent, since 14-07-2022
- Financial year end
- 30 June
- Peppol
- Reachable since 31-12-2025
Board and ownership
- NUTTIN EvyDirector · since 06-02-2022
- NUTTIN Evy1,000 sharesact of 18-07-2022
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.0%
- Gross margin
- €32,261
- ▼ 19.7%
- Turnover
- ≈ €93,000
- estimated
- Profit
- €22,476
- ▼ 7.2%
- Equity
- €47,687
- ▲ 89.2%
- Total assets
- €63,524
- ▲ 54.3%
- 2025 accounts filed 2 days after the deadline
Score breakdownraises risk1 change of registered office in 24 monthsLiquidity: current ratio 3.13, cash €158, halvedFounded in 2022lowers riskSector: Activities of head offices; management consultancy activities (NACE 70)Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 86% of them on solvency, 21% on liquidity, 84% on profitability and 88% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 2 accounts on average 3 days after the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
2025 annual accounts filed 2 days after the deadline Filed on 2 February 2026, deadline 31 January 2026 (7 months after the close on 30 June 2025, Companies Code art. 3:10). Source: NBB, 2026-00034976.
Annual accounts 2025 filed on 02-02-2026 PDF all 2 filings
Every figure per financial year
The operating result for 2025 is 23% lower than in 2024.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Investments
| Item | 30-06-2024 | 30-06-2025 |
|---|---|---|
| Tangible fixed assets | €5,218 | €11,783 |
| Depreciation and write-downs of the year | €1,044 | €2,039 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Subsidies and aid
Flemish government
2022 to 2024 · 3 entries · €1,276 awarded · €1,203 paid| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2024 | 1 | €286 | €212 |
| 2023 | 1 | €840 | €878 |
| 2022 | 1 | €150 | €113 |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,044 | €2,039 | ▲ 95.3% |
| Other operating charges640/8 | €1,440 | €1,243 | ▼ 13.7% |
| Gross operating margin9900 | €40,184 | €32,261 | ▼ 19.7% |
| Operating profit (loss)9901 | €37,701 | €28,979 | ▼ 23.1% |
| Financial income75/76B | €1,319 | €1,690 | ▲ 28.1% |
| Recurring financial income75 | €1,319 | €1,690 | ▲ 28.1% |
| Financial charges65/66B | €2,514 | €1,813 | ▼ 27.9% |
| Recurring financial charges65 | €2,514 | €1,813 | ▼ 27.9% |
| Profit (loss) for the period before taxes9903 | €36,505 | €28,856 | ▼ 21.0% |
| Income taxes67/77 | €12,295 | €6,380 | ▼ 48.1% |
| Profit (loss) for the period9904 | €24,211 | €22,476 | ▼ 7.2% |
| Profit (loss) for the period to be appropriated9905 | €24,211 | €22,476 | ▼ 7.2% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €41,177 | €63,524 | ▲ 54.3% |
| Fixed assets21/28 | €4,175 | €13,919 | ▲ 233% |
| Tangible fixed assets22/27 | €4,175 | €13,919 | ▲ 233% |
| Furniture and vehicles24 | €4,175 | €13,919 | ▲ 233% |
| Current assets29/58 | €37,002 | €49,604 | ▲ 34.1% |
| Amounts receivable within one year40/41 | €26,383 | €49,446 | ▲ 87.4% |
| Trade receivables40 | €581 | €14,157 | ▲ 24× |
| Other amounts receivable41 | €25,802 | €35,289 | ▲ 36.8% |
| Cash at bank and in hand54/58 | €10,620 | €158 | ▼ 98.5% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €41,177 | €63,524 | ▲ 54.3% |
| Equity10/15 | €25,211 | €47,687 | ▲ 89.2% |
| Contributions10/11 | €1,000 | €1,000 | = |
| Reserves13 | €24,211 | €46,687 | ▲ 92.8% |
| Distributable reserves133 | €24,211 | €46,687 | ▲ 92.8% |
| Amounts payable17/49 | €15,966 | €15,837 | ▼ 0.8% |
| Amounts payable after more than one year17 | €101 | - | - |
| Financial debts170/4 | €101 | - | - |
| Amounts payable within one year42/48 | €15,865 | €15,837 | ▼ 0.2% |
| Current portion of amounts payable after more than one year42 | €1,179 | €101 | ▼ 91.4% |
| Trade debts44 | €250 | €833 | ▲ 233% |
| Suppliers440/4 | €250 | €833 | ▲ 233% |
| Taxes, remuneration and social security45 | €14,436 | €14,903 | ▲ 3.2% |
| Taxes450/3 | €14,436 | €14,903 | ▲ 3.2% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €24,211 | €22,476 | ▼ 7.2% |
| + Depreciation and write-downs630 | €1,044 | €2,039 | ▲ 95.3% |
| Operating cash flow (approximation) | €25,254 | €24,515 | ▼ 2.9% |
| Investment in fixed assets (approximation) | - | -€11,783 | - |
| Change in cash | - | -€10,462 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 39,278 companies had the same profile as OFFMANAGE has now. Two years later, 95.8% were still going and 1.8% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of OFFMANAGE itself: 1.0% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for OFFMANAGE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Board & ownership
Directors
Owners and capital
Shareholders
- NUTTIN Evy 1,000 shares (100%) · €1,000
Capital transactions
- 18-07-2022 Incorporation · 1,000 shares
Mandate history
- Board
- end not dated
| Name | Functions and periods |
|---|---|
| NUTTIN Evy |
|
| VERSCHAEVE Sean Robbie Jeannine |
|
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Articles of association, deed of 18-07-2022 (in Dutch)
Network & group
OFFMANAGE shares no director with another company.
Companies at the same address
1 other companyConnections & network
1 current directorThe network starts from the directors of OFFMANAGE. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
07-07
Gazette deed
Registered office moved within GhentNew seat: Jozef Plateaustraat 23/201, 9000 Gent · Previous seat: Kunstlaan 41, 9000 Gent10 points ▸
- General meeting, 05-02-2026
- Registered-office move, Jozef Plateaustraat 23/201, 9000 Gent
- Power of attorney, Kelly Verpoorten
- Power of attorney, Sara Heemskerk
- Power of attorney, Sandy Van de Leur
- Power of attorney, Kristel Van Gysel
- Power of attorney, Héloïse Debrandt
- Power of attorney, Viktorija Coric
- Power of attorney, Sara Szurgot
- Power of attorney, Kanella Venetsanos
- The act holds 1 more point.
18-07
Gazette deed
IncorporationFounder: NUTTIN Evy (oprichter comparante) · 1,000 shares · Appointments: NUTTIN Evy (statutory director) and VERSCHAEVE Sean Robbie Jeannine (statutory director)7 points ▸
- Incorporation, 06-07-2022
- Founder, NUTTIN Evy (oprichter comparante)
- 1,000 shares
- Director appointment, NUTTIN Evy (statutory director)
- Director appointment, VERSCHAEVE Sean Robbie Jeannine (statutory director)
- Registered office clause, Kunstlaan 41, 9000 Gent
- Power of attorney, Michel Willems
- The act holds 4 more points.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Codes under NACEBEL 2008
26 activities
- In eigen naam
- In naam van derden
- Voor eigen rekening
- Voor rekening van derden
- In deelneming van derden
- Management, marketing en bedrijfsbeheer in ruime zin, aan organisaties
- Financieel beleid van organisaties
- Boekhouding en administratie
- Management, marketing en bedrijfsbeheer in ruime zin
- Public relations en communicatie
- Human resources advies aan organisaties
- Sales support
- Office management
- De aankoop, verkoop en ruiling, het beheer en de valorisatie van haar eigen roerend patrimonium, bestaande uit onder meer waardepapieren, aandelen, obligaties, staatsfondsen en van alle roerende goederen en rechten, inbegrepen handelszaken
- Het verwerven en beheren van participaties, in eender welke vorm, in alle bestaande of op te richten vennootschappen, ondernemingen, economische samenwerkingsverbanden, beroepsverenigingen of groeperingen, evenals het verlenen van alle managementbijstand en het uitoefenen van alle bestuursmandaten, volmachtdrager, mandataris of vereffenaar en het ter beschikking stellen van personen gespecialiseerd in het adviseren en/of besturen van ondernemingen, dit alles in de meest ruime zin
- Het stimuleren, de planning en coördinatie van de ontwikkeling van vennootschappen en ondernemingen; het deelnemen aan het beheer, bestuur en toezicht van alsmede het verlenen van technische, administratieve en financiële bijstand aan vennootschappen en ondernemingen waarin zij rechtstreeks of onrechtstreeks enig belang heeft
- In het raam van haar thesauriebeheer, het rechtstreeks uitvoeren of door toedoen van vestigingen in België of in het buitenland van trading en deviezenoperaties en de tussenkomst in de emissie en plaatsing van aandelen, obligaties en allerhande effecten; Alle verbintenissen van borgtocht, aval of van eender welke garanties; het verstrekken van leningen, voorschotten of borgstellingen. De vennootschap mag ten voordele van derden tevens waarborgen toestaan, alle roerende waarden verpanden en alle onroerende goederen met hypotheek bezwaren
- Het beheren van een eigen onroerend patrimonium en het valoriseren van dit patrimonium vooral door beheersdaden, zoals onroerende goederen verwerven, laten bouwen en verbouwen, laten opschikken, laten uitrusten, ombouwen, verfraaien, in huur geven of nemen, in leasing geven of nemen, verkavelen, onderhouden, ontwikkelen en uitbaten, urbaniseren, vervreemden en ruilen met het oog op beheer, wederbelegging en opbrengst
- Projectontwikkeling in de bouw en toezicht op de bouwwerkzaamheden
- Het verlenen van chemisch en medicinaal chemisch advies dat kan resulteren in het identificeren van mogelijke bestanddelen en moleculen die kunnen leiden tot het ontwikkelen van nieuwe behandelingsmethoden of medicijnen voor de behandeling van uiteenlopende ziekten zoals, maar niet beperkend, kanker, infecties, problemen met het centraal zenuwstelsel, pijn, hart en vasculaire ziekten of immuniteitsstoornissen. De vennootschap kan zich hiertoe begeven op diverse onderzoeksterreinen die het identificeren van deze zogenaamde actieve bestanddelen kunnen versnellen en verbeteren. Zij kan daarbij haar onderzoeksmethoden aanwenden, bestendig verbeteren en constant vernieuwen. Maar eveneens kan zij alle activiteiten ontwikkelen die haar toelaten moleculen te bedenken, te synthetiseren, te testen, preklinische en klinische proeven te ondernemen en alle procedures te doorlopen die haar toelaten de ontwikkelde geneesmiddelen te commercialiseren, in licentie te geven of op enige andere wijze ten gelde te maken
- Het uitvoeren van elke vorm van onderzoek in het domein van verbindingen en moleculen, alsook de productie, de industrialisering en commercialisering van de resultaten hiervan. Het onderzoek naar en de ontwikkeling van biologische, biotechnologische of afgeleide producten met een marktwaarde in het domein van de humane of veterinaire gezondheidszorg, zoals, niet beperkend, diagnostica, therapeutica, cosmetica en voedingsadditieven.
- Het verstrekken van adviezen inzake octrooien en octrooi strategie, inzake het aanvragen van financiële steun voor het verrichten van onderzoek, inzake de evaluatie van (pre)klinische kandidaat moleculen en dit zowel voor de farmaceutische, de biotechnologische als andere sectoren van de chemische indsutrie.
- Het verlenen van chemisch advies
- Die leiden tt moleculen voor andere marktsectoren zoals, maar niet beperkend, de agrochemische of analytische sectoren
- Gebaseerd p andere technieken moleculen ontwikkelen en/of op de markt brengen.
- De opleiding en training van personen in het verwerven van chemische en medicinaal chemische kennis.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 44805E1336/00K002 | Flanders | 274 m² | 1 · 138 m² | 18.4 m · 5 |